Quince Therapeutics, Inc. (QNCX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 25.58M | 22.9M | 29.2M | 37.34M | 33.83M | 44.04M | 51.72M | 63.44M | 70.44M | 77.44M | 85.17M | 88.55M |
| Cash & Short-Term Investments | 18.16M | 17.75M | 26.29M | 34.71M | 31.6M | 40.78M | 47.85M | 59.45M | 67.82M | 75.06M | 83.22M | 87.56M |
| Cash Only | 18.16M | 5.81M | 6.45M | 16.83M | 7.77M | 6.21M | 2.67M | 7.89M | 21.81M | 20.75M | 21.63M | 22.65M |
| Short-Term Investments | 0 | 11.94M | 19.84M | 17.88M | 23.83M | 34.57M | 45.17M | 51.55M | 46.01M | 54.31M | 61.59M | 64.92M |
| Accounts Receivable | 5.27M | 3.62M | 0 | 992K | 916K | 882K | 995K | 964K | 971K | 993K | 500K | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.31M | 1.52M | 1.09M | 55K | 32K | 84K | 55K | 79K | 48K | 81K | 141K | 405K |
| Total Non-Current Assets | 1.04M | 70.63M | 80.7M | 79.86M | 73.26M | 70.44M | 74.8M | 71.39M | 88.85M | 102.76M | 213K | 288K |
| Property, Plant & Equipment | 965K | 1.05M | 1.1M | 1.08M | 941K | 813K | 767K | 800K | 810K | 619K | 53K | 116K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.25M | 17.63M | 0 | 0 |
| Intangible Assets | 0 | 67.82M | 67.73M | 67.57M | 62.36M | 60.05M | 64.53M | 61.79M | 62.25M | 63.67M | 0 | 0 |
| Long-Term Investments | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K |
| Other Non-Current Assets | 0 | 1.68M | 11.8M | 11.14M | 9.88M | 9.51M | 9.43M | 8.72M | 8.47M | 8.47M | 82K | 94K |
| Total Assets | 26.62M | 93.52M | 109.9M | 117.21M | 107.09M | 114.48M | 126.52M | 134.83M | 159.29M | 180.2M | 85.39M | 88.84M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -75.14% | -18.3% | -13.14% | -13.07% | -32.77% | -36.47% | 48.17% | 51.77% | 70.7% | 73.42% | -22.22% | -24.63% |
| Total Current Liabilities | 8.77M | 43.23M | 26.04M | 7.47M | 8.36M | 7.28M | 5.42M | 10.32M | 9.84M | 9.57M | 2.25M | 1.95M |
| Accounts Payable | 5.39M | 2.22M | 3.4M | 1.76M | 3.01M | 2.9M | 1.62M | 2.4M | 2.07M | 2.03M | 409K | 353K |
| Days Payables Outstanding | 9.52K | - | - | 6.2K | - | 13.01K | - | - | - | 369.51 | - | - |
| Short-Term Debt | 113K | 18.03M | 17.63M | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.39M | 22.98M | 2.4M | 180K | 233K | 308K | 198K | 5.28M | 5.04M | 5.13M | 151K | 83K |
| Current Ratio | 2.92x | 0.53x | 1.12x | 5.00x | 4.05x | 6.05x | 9.53x | 6.15x | 7.16x | 8.09x | 37.80x | 45.36x |
| Quick Ratio | 2.92x | 0.53x | 1.12x | 5.00x | 4.05x | 6.05x | 9.53x | 6.15x | 7.16x | 8.09x | 37.80x | 45.36x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.18M | 86.01M | 82.8M | 98.01M | 80.15M | 77.05M | 76.16M | 77.54M | 75.28M | 85.55M | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 16.99M | 15.27M | 14.32M | 14.9M | 13.83M | 13.52M | 13.43M | 0 | 0 |
| Capital Lease Obligations | 293K | 330K | 359K | 387K | 383K | 394K | 450K | 453K | 480K | 321K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 109K | 5.59M | 5.59M | 5.17M | 4.96M | 5.38M | 5.17M | 5.18M | 17.61M | 0 | 0 |
| Other Non-Current Liabilities | 1.89M | 85.68M | 76.84M | 75.04M | 59.33M | 57.38M | 55.43M | 58.08M | 56.1M | 54.19M | 0 | 0 |
| Total Liabilities | 10.95M | 129.24M | 108.84M | 105.47M | 88.51M | 84.33M | 81.59M | 87.86M | 85.11M | 95.12M | 2.25M | 1.95M |
| Total Debt | 406K | 18.36M | 17.99M | 17.49M | 15.75M | 14.81M | 15.45M | 14.38M | 14.09M | 13.81M | 61K | 147K |
| Net Debt | -17.76M | 12.55M | 11.54M | 662K | 7.98M | 8.6M | 12.78M | 6.49M | -7.72M | -6.94M | -21.57M | -22.5M |
| Debt / Equity | 0.03x | - | 16.99x | 1.49x | 0.85x | 0.49x | 0.34x | 0.31x | 0.19x | 0.16x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 15.67M | -35.71M | 1.06M | 11.74M | 18.58M | 30.15M | 44.93M | 46.97M | 74.18M | 85.08M | 83.13M | 86.88M |
| Equity Growth % | -15.66% | -218.47% | -97.64% | -75.01% | -74.95% | -64.57% | -45.95% | -45.94% | -17.77% | -15.42% | -20.47% | -22.1% |
| Book Value per Share | 3.13 | -7.13 | 0.20 | 2.51 | 4.23 | 6.97 | 10.41 | 10.90 | 17.25 | 20.77 | 23.05 | 24.19 |
| Total Shareholders' Equity | 15.67M | -35.71M | 1.06M | 11.74M | 18.58M | 30.15M | 44.93M | 46.97M | 74.18M | 85.08M | 83.13M | 86.88M |
| Common Stock | 14K | 55K | 54K | 53K | 44K | 44K | 43K | 43K | 43K | 43K | 36K | 36K |
| Retained Earnings | -424.54M | -460.45M | -420.99M | -407.55M | -391.5M | -376.47M | -364.01M | -358.52M | -330.79M | -319.64M | -310.75M | -305.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4.61M | 5.75M | 6.29M | 6.16M | 1.96M | -35K | 3.42M | 1.09M | 1.82M | 3.05M | 516K | 257K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |